CA2536194A1 - Procede et appareil pour reanimation cardiaque - Google Patents
Procede et appareil pour reanimation cardiaque Download PDFInfo
- Publication number
- CA2536194A1 CA2536194A1 CA002536194A CA2536194A CA2536194A1 CA 2536194 A1 CA2536194 A1 CA 2536194A1 CA 002536194 A CA002536194 A CA 002536194A CA 2536194 A CA2536194 A CA 2536194A CA 2536194 A1 CA2536194 A1 CA 2536194A1
- Authority
- CA
- Canada
- Prior art keywords
- delivering
- heart
- series
- cardiac
- pulses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000747 cardiac effect Effects 0.000 title claims abstract description 101
- 238000000034 method Methods 0.000 title claims abstract description 64
- 208000003663 ventricular fibrillation Diseases 0.000 claims abstract description 71
- 206010021143 Hypoxia Diseases 0.000 claims abstract description 32
- 230000007954 hypoxia Effects 0.000 claims abstract description 29
- 238000002680 cardiopulmonary resuscitation Methods 0.000 claims abstract description 27
- 230000002107 myocardial effect Effects 0.000 claims abstract description 12
- 230000002459 sustained effect Effects 0.000 claims abstract description 11
- 230000002861 ventricular Effects 0.000 claims abstract description 8
- 238000002560 therapeutic procedure Methods 0.000 claims description 40
- 208000010496 Heart Arrest Diseases 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 24
- 230000002999 depolarising effect Effects 0.000 claims description 18
- 238000001514 detection method Methods 0.000 claims description 17
- 230000006835 compression Effects 0.000 claims description 11
- 238000007906 compression Methods 0.000 claims description 11
- 206010003119 arrhythmia Diseases 0.000 claims description 9
- 230000006793 arrhythmia Effects 0.000 claims description 8
- 230000000977 initiatory effect Effects 0.000 claims description 5
- 230000000007 visual effect Effects 0.000 claims description 4
- 238000006213 oxygenation reaction Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims 7
- 210000004165 myocardium Anatomy 0.000 claims 5
- 230000003213 activating effect Effects 0.000 claims 2
- 208000009378 Low Cardiac Output Diseases 0.000 claims 1
- 231100000518 lethal Toxicity 0.000 claims 1
- 230000001665 lethal effect Effects 0.000 claims 1
- 150000002926 oxygen Chemical class 0.000 claims 1
- 230000000737 periodic effect Effects 0.000 claims 1
- 210000005166 vasculature Anatomy 0.000 claims 1
- 230000000638 stimulation Effects 0.000 abstract description 110
- 230000028161 membrane depolarization Effects 0.000 abstract description 22
- 206010047284 Ventricular asystole Diseases 0.000 abstract description 14
- 230000000763 evoking effect Effects 0.000 abstract description 2
- 238000002618 extracorporeal membrane oxygenation Methods 0.000 abstract description 2
- 230000004913 activation Effects 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 description 56
- 239000011575 calcium Substances 0.000 description 56
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 55
- 230000035939 shock Effects 0.000 description 26
- 230000002035 prolonged effect Effects 0.000 description 19
- 238000010586 diagram Methods 0.000 description 18
- 230000002600 fibrillogenic effect Effects 0.000 description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- 206010061592 cardiac fibrillation Diseases 0.000 description 15
- 238000013194 cardioversion Methods 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 15
- 229910052760 oxygen Inorganic materials 0.000 description 15
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 14
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 14
- 206010058151 Pulseless electrical activity Diseases 0.000 description 10
- 230000033764 rhythmic process Effects 0.000 description 10
- 208000001871 Tachycardia Diseases 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 210000000038 chest Anatomy 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000000107 myocyte Anatomy 0.000 description 9
- 238000004904 shortening Methods 0.000 description 9
- 230000000004 hemodynamic effect Effects 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 101000936911 Chionoecetes opilio Sarcoplasmic/endoplasmic reticulum calcium ATPase Proteins 0.000 description 7
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000001351 cycling effect Effects 0.000 description 7
- 108091005975 Myofilaments Proteins 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 210000003632 microfilament Anatomy 0.000 description 6
- 108091006146 Channels Proteins 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000010412 perfusion Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- 230000006794 tachycardia Effects 0.000 description 5
- 206010047302 ventricular tachycardia Diseases 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000002235 sarcomere Anatomy 0.000 description 4
- 206010065341 Ventricular tachyarrhythmia Diseases 0.000 description 3
- 230000036982 action potential Effects 0.000 description 3
- 230000036471 bradycardia Effects 0.000 description 3
- 208000006218 bradycardia Diseases 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 230000001146 hypoxic effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- 108090000312 Calcium Channels Proteins 0.000 description 2
- 102000003922 Calcium Channels Human genes 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229930001406 Ryanodine Natural products 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000005242 cardiac chamber Anatomy 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000001862 defibrillatory effect Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004941 influx Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- JJSYXNQGLHBRRK-SFEDZAPPSA-N ryanodine Chemical compound O([C@@H]1[C@]([C@@]2([C@]3(O)[C@]45O[C@@]2(O)C[C@]([C@]4(CC[C@H](C)[C@H]5O)O)(C)[C@@]31O)C)(O)C(C)C)C(=O)C1=CC=CN1 JJSYXNQGLHBRRK-SFEDZAPPSA-N 0.000 description 2
- 230000009919 sequestration Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000004957 Out-of-Hospital Cardiac Arrest Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000059 bradycardiac effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 230000009460 calcium influx Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000007635 classification algorithm Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000010291 electrical method Methods 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000010222 extracellular calcium influx Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 238000002633 shock therapy Methods 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H31/00—Artificial respiration by a force applied to the chest; Heart stimulation, e.g. heart massage
- A61H31/004—Heart stimulation
- A61H31/005—Heart stimulation with feedback for the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H31/00—Artificial respiration by a force applied to the chest; Heart stimulation, e.g. heart massage
- A61H31/004—Heart stimulation
- A61H31/006—Power driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3621—Heart stimulators for treating or preventing abnormally high heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3904—External heart defibrillators [EHD]
- A61N1/39044—External heart defibrillators [EHD] in combination with cardiopulmonary resuscitation [CPR] therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
- A61N1/3962—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
- A61N1/39622—Pacing therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/50—Control means thereof
- A61H2201/5007—Control means thereof computer controlled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2230/00—Measuring physical parameters of the user
- A61H2230/04—Heartbeat characteristics, e.g. E.G.C., blood pressure modulation
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Critical Care (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Electrotherapy Devices (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64664103A | 2003-08-22 | 2003-08-22 | |
| US10/646,641 | 2003-08-22 | ||
| PCT/US2004/026946 WO2005021089A1 (fr) | 2003-08-22 | 2004-08-20 | Procede et appareil pour reanimation cardiaque |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2536194A1 true CA2536194A1 (fr) | 2005-03-10 |
Family
ID=34273294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002536194A Abandoned CA2536194A1 (fr) | 2003-08-22 | 2004-08-20 | Procede et appareil pour reanimation cardiaque |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1667767A1 (fr) |
| JP (1) | JP2007503257A (fr) |
| CA (1) | CA2536194A1 (fr) |
| IL (1) | IL173772A0 (fr) |
| WO (1) | WO2005021089A1 (fr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050131465A1 (en) | 2000-02-04 | 2005-06-16 | Freeman Gary A. | Integrated resuscitation |
| AU2001234846A1 (en) | 2000-02-04 | 2001-08-14 | Zmd Corporation | Integrated resuscitation |
| US6961612B2 (en) | 2003-02-19 | 2005-11-01 | Zoll Medical Corporation | CPR sensitive ECG analysis in an automatic external defibrillator |
| US20050101889A1 (en) | 2003-11-06 | 2005-05-12 | Freeman Gary A. | Using chest velocity to process physiological signals to remove chest compression artifacts |
| JP2012091021A (ja) | 2003-11-06 | 2012-05-17 | Zoll Medical Corp | 胸部圧迫適用中の生理学的信号を解析する装置 |
| WO2005112749A1 (fr) | 2004-05-12 | 2005-12-01 | Zoll Medical Corporation | Procede de recommandation pour rythme ecg |
| US7565194B2 (en) | 2004-05-12 | 2009-07-21 | Zoll Medical Corporation | ECG rhythm advisory method |
| US7650181B2 (en) * | 2005-09-14 | 2010-01-19 | Zoll Medical Corporation | Synchronization of repetitive therapeutic interventions |
| EP2224892B1 (fr) | 2007-11-01 | 2016-05-04 | Zoll Medical Corporation | Synchronisation d'une défibrillation et de compressions thoraciques |
| US10238574B2 (en) | 2011-04-08 | 2019-03-26 | Zoll Medical Corporation | System for assisting rescuers in performing cardio-pulmonary resuscitation (CPR) on a patient |
| JP6013447B2 (ja) * | 2011-04-08 | 2016-10-25 | ゾール メディカル コーポレイションＺＯＬＬ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ | 連携式蘇生灌流支援 |
| US8942800B2 (en) | 2012-04-20 | 2015-01-27 | Cardiac Science Corporation | Corrective prompting system for appropriate chest compressions |
| US20140323928A1 (en) | 2013-04-30 | 2014-10-30 | Zoll Medical Corporation | Compression Depth Monitor with Variable Release Velocity Feedback |
| US20150088016A1 (en) | 2013-09-25 | 2015-03-26 | Zoll Medical Corporation | Mobile Device Control |
| EP4249041B1 (fr) | 2015-10-16 | 2025-03-12 | Zoll Medical Corporation | Électrodes à double capteur permettant d'améliorer la rétroaction d'un appareil de réanimation |
| US11179293B2 (en) | 2017-07-28 | 2021-11-23 | Stryker Corporation | Patient support system with chest compression system and harness assembly with sensor system |
| WO2022051672A1 (fr) | 2020-09-04 | 2022-03-10 | Zoll Medical Corporation | Système de traitement médical avec dispositif compagnon |
| US12232851B2 (en) | 2021-03-08 | 2025-02-25 | Medtronic, Inc. | Acute health event monitoring |
| US11633112B2 (en) | 2021-03-08 | 2023-04-25 | Medtronic, Inc. | Automatic alert control for acute health event |
| KR102489017B1 (ko) | 2022-07-20 | 2023-01-18 | 주식회사 씨유메디칼시스템 | 환자의 흉부 압박 및 제세동을 위한 응급치료장치와 환자의 흉부 압박 깊이 소실 보정방법 |
| KR102466440B1 (ko) | 2022-07-22 | 2022-11-15 | 주식회사 씨유메디칼시스템 | 흉부 임피던스를 이용한 심폐소생술장치 및 자동심장충격기 융합 시스템 |
| KR102499151B1 (ko) | 2022-08-02 | 2023-02-13 | 주식회사 씨유메디칼시스템 | 심폐소생술장치의 피스톤 커버 |
| KR102499150B1 (ko) | 2022-08-02 | 2023-02-13 | 주식회사 씨유메디칼시스템 | 심폐소생술장치의 피스톤 캡 |
| KR102499152B1 (ko) | 2022-08-02 | 2023-02-14 | 주식회사 씨유메디칼시스템 | 심폐소생술장치의 피스톤 캡 제조방법 |
| KR102565053B1 (ko) | 2022-12-15 | 2023-08-10 | 주식회사 씨유메디칼시스템 | 심폐소생술장치의 피스톤 커버 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1199371A (fr) * | 1982-12-03 | 1986-01-14 | Orest Z. Roy | Stimulation ultrasonique des contractions cardiaques synchronisee avec des phases de l'ecg ou avec un defibrillateur |
| US5626618A (en) * | 1993-09-24 | 1997-05-06 | The Ohio State University | Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring |
| US6463327B1 (en) * | 1998-06-11 | 2002-10-08 | Cprx Llc | Stimulatory device and methods to electrically stimulate the phrenic nerve |
| US6390996B1 (en) * | 1998-11-09 | 2002-05-21 | The Johns Hopkins University | CPR chest compression monitor |
-
2004
- 2004-08-20 EP EP04781603A patent/EP1667767A1/fr not_active Withdrawn
- 2004-08-20 WO PCT/US2004/026946 patent/WO2005021089A1/fr not_active Ceased
- 2004-08-20 JP JP2006524732A patent/JP2007503257A/ja active Pending
- 2004-08-20 CA CA002536194A patent/CA2536194A1/fr not_active Abandoned
-
2006
- 2006-02-16 IL IL173772A patent/IL173772A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1667767A1 (fr) | 2006-06-14 |
| IL173772A0 (en) | 2006-07-05 |
| WO2005021089A1 (fr) | 2005-03-10 |
| JP2007503257A (ja) | 2007-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2536194A1 (fr) | Procede et appareil pour reanimation cardiaque | |
| US6298267B1 (en) | Method and apparatus for treatment of cardiac electromechanical dissociation | |
| US6259949B1 (en) | Method and apparatus for treatment of cardiac electromechanical dissociation | |
| US6760621B2 (en) | Method for improving cardiac function following delivery of a defibrillation shock | |
| US7957799B2 (en) | Non-invasive cardiac potentiation therapy | |
| US5620468A (en) | Method and apparatus for treatment of atrial fibrillation | |
| CN109069848B (zh) | 植入式复律除颤器中的心搏停止检测和响应 | |
| WO2000057955A1 (fr) | Technique et dispositif destines a imposer electriquement un debit cardiaque chez un patient arythmique | |
| EP1076582A2 (fr) | Procede et appareil destines a attenuer la douleur dans le cadre de therapies par stimulation electrique | |
| JPH09103499A (ja) | 心筋刺激器および心臓ペーサ／カーディオバータ／除細動器の組合わせ装置 | |
| US8517013B2 (en) | Pacing management during cardiopulmonary resuscitation | |
| US6230056B1 (en) | Method and apparatus for preventing clotting during a trial fibrillation | |
| US7164944B1 (en) | Analgesic therapy for ICD patients | |
| US5632716A (en) | Apparatus and method of muscle training in dynamic cardiomyoplasty | |
| US20040138713A1 (en) | External defibrillation and transcutaneous pacing device and methods for operating the device | |
| US9144684B2 (en) | Medium voltage therapy applied as a test of a physiologic state | |
| Rosborough et al. | Electrical therapy for post defibrillatory pulseless electrical activity | |
| US20080249584A1 (en) | Method and device for cardiosympathetic inhibition | |
| US7761156B2 (en) | Method for operating an implantable cardiac stimulator to set the atrial stimulation time interval dependent on the evoked response amplitude | |
| JP2024530567A (ja) | 抗頻脈及び／又はショック治療をもたらすための埋め込み型システム及び方法 | |
| WO2000013748A1 (fr) | Procede et appareil de prevention de coagulation lors d"une fibrillation auriculaire | |
| Klemm et al. | Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock: Br J Pharmacol 1995; 114/2: 363–368 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |